Aligos Therapeutics (ALGS) Earnings Date & Reports
A.I. Advisor
published Earnings
ALGS is expected to report earnings to fall 666.67% to -17 cents per share on October 31
Q3'24
Est.
$-0.17
Q2'24
Beat
by $0.19
Q1'24
Missed
by $0.03
Q4'23
Beat
by $0.06
Q3'23
Beat
by $0.07
The last earnings report on August 06 showed earnings per share of 2 cents, beating the estimate of -15 cents. With 51.46K shares outstanding, the current market capitalization sits at 25.70M.